Sergio Capaccioli holds a Ph.D. degree in biological sciences. He has been a Professor of general pathology and oncology at the Faculties of Medicine and of Pharmacy of the University of Florence since 1983. In 2011, he was the President of Associazione per l'Ingegneria dei Tessuti (A.I.T.) and in 2009 the President of Phoenix Stem Cell Foundation for Human Life (ONLUS). In 1994, he was a Visiting Scientist at the Biochemistry of the Cell Nucleus Laboratory (Staff Scientist Gerard Evan) in the Imperial Cancer Research Fund, London, and in 1996, a Visiting Professor at the Laboratory of Adaptive Systems (Staff Scientist Daniel Alkon) in NINDS (NIH), Bethesda (1996). In 1998, he won the Special Florence Prize, founded by the Cultural Association Florence-Europe and European Parliament, with citation for his scientific achievements in oncology. In 2003, he was the Chairperson of the Organizing Committee and a Member of the Advisory Board of the First International Meeting on ARE's and AUBP's in mRNA stability and translational control, under the auspices of RNA Society, Florence (Italy). Moreover, he was a Project Leader in several research projects granted by MIUR, CNR, AIRC, ECRF, and the pharmaceutical companies IBI, Menarini, and Visufarma. Capaccioli is a Member of the following scientific societies: American Society for Biochemistry and Molecular Biology (ASBMB), Italian Society of Pathology (SIP), Italian Society of Chemotherapy (SIC), Italian Society of Cancerology (SIC), International Union of Nucleic Acid Chemistry (IUNAC), Italian Association of Cell Biology and Differentiation Association (ABCD), and Italian College of Applied Molecular Medicine (ICAMM). His main interests include apoptosis alterations in cancer and degenerative diseases and alterations of posttranscriptional control in Cancer.
Biography Updated on 19 December 2011